What drugs target ALK tyrosine kinase receptor?

6+ drugs target ALK tyrosine kinase receptor, including Tagrisso, Lorbrena, Alecensa, Alunbrig, Lorbrena.

What drug classes act on ALK tyrosine kinase receptor?

Drug classes acting on ALK tyrosine kinase receptor include Kinase Inhibitor [EPC], Kinase Inhibitor.

6 drugs 6 marketed

All drugs that target ALK tyrosine kinase receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Tagrisso · AstraZeneca · Kinase Inhibitor [EPC] · Oncology
Osimertinib is a kinase inhibitor of the epidermal growth factor receptor (EGFR) that binds irreversibly to mutant forms of EGFR.
Lorbrena · Pfizer · Kinase Inhibitor [EPC] · Oncology
Lorbrena works by blocking the activity of the ALK tyrosine kinase receptor, which is a protein that helps cancer cells grow.
Alecensa · Hoffmann-La Roche · Kinase Inhibitor · Oncology
Alecensa blocks the activity of the ALK protein, which is involved in the growth and spread of cancer cells.
Alunbrig · Takeda · Kinase Inhibitor [EPC] · Oncology
Alunbrig works by blocking the activity of the ALK tyrosine kinase receptor, which is involved in the growth and spread of cancer cells.
Lorbrena · Pfizer · Kinase Inhibitor [EPC] · Oncology
Lorbrena works by blocking the activity of the ALK tyrosine kinase receptor, which is a protein that helps cancer cells grow.
Zykadia · Novartis · Kinase Inhibitor [EPC] · Oncology
Zykadia blocks the activity of the ALK protein, which is involved in the growth and spread of cancer cells.